Jessie Villanueva

4PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 05, 2025
Selective abrogation of S6K2 identifies lipid homeostasis as a survival vulnerability in MAPK inhibitor-resistant NRAS-mutant melanoma.

Brittany Lipchick, Adam N Guterres, Hsin-Yi Chen

|Aug 01, 2020
Targeting telomerase for cancer therapy.

Adam N Guterres, Jessie Villanueva

|Aug 18, 2018
Tailoring Chemotherapy for the African-Centric S47 Variant of TP53.

Thibaut Barnoud, Anna Budina-Kolomets, Subhasree Basu

|Apr 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma.

Ileabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres

Pageof 1